Viacom May Tighten Reins on Paramount

Related Link: 

Paramount Chief Executive Brad Grey and his team are under pressure from the Viacom board to defend their film record and present a turnaround plan.

U.S. Durable-Goods Orders Rebounded in July, Jumping 4.4%

Related Link: 

Demand for long-lasting factory goods rebounded in July—with durable-goods orders leaping 4.4%—in a sign the manufacturing sector could continue to stabilize in the second half of the year.

Why China's Overseas Oil Adventurer Can't Cut Costs Forever

Related Link: 

Cnooc’s low level of overall oil reserves means it will have to undo cost cuts at some point.

Indian Firm Admits 'Error' After Target Cuts Ties Over Cotton Dispute

Related Link: 

Welspun India said it would modify its supply chain and review its practices to address accusations it sold fake Egyptian cotton sheets to U.S. retailers.

Mylan Boosts Price Assistance for EpiPen Amid Backlash

Related Link: 

Mylan responded to backlash over the price of its EpiPen by promising to reduce the costs that some patients pay, though stopped short of saying it would cut prices.

Mixed-Up German Data Pose Challenge for Investors

Related Link: 

As soon as investors gain any measure of confidence, a piece of information arrives to challenge it. The surprise decline in Germany’s Ifo index is the latest example.

Sears Posts Loss as Revenue Slides

Related Link: 

Sears Holdings reported improved core results for its fiscal second quarter, helped in part by lower costs, but the retailer still posted a loss amid sliding sales.

What to Learn From the ECB's Great European Corporate Bond Squeeze

Related Link: 

The European corporate bond market is heading into ever more extraordinary territory.

China's Decline in Oil Production Echoes Globally

Related Link: 

Oil production in China likely peaked last year at around 4.3 million barrels a day, a development that has significant implications, including the potential for higher crude prices over time as China steps up imports to meet rising demand at home.

Germany's Merck Beefs Up Non-Drug Businesses

Related Link: 

Merck KGaA is expanding its specialty chemicals and lab equipment operations to keep its revenue and profit growing despite recent drug-development stumbles.

Syndicate content